See more : Fincantieri S.p.A. (FCT.MI) Income Statement Analysis – Financial Results
Complete financial analysis of Butterfly Network, Inc. (BFLY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Butterfly Network, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Gfinity plc (GFIN.L) Income Statement Analysis – Financial Results
- Global Technologies, Ltd. (GTLL) Income Statement Analysis – Financial Results
- PT. Polychem Indonesia Tbk (ADMG.JK) Income Statement Analysis – Financial Results
- Zeon Corporation (4205.T) Income Statement Analysis – Financial Results
- Silex Systems Limited (SLX.AX) Income Statement Analysis – Financial Results
Butterfly Network, Inc. (BFLY)
About Butterfly Network, Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smartphone, tablet, and hospital computer system; and Butterfly Blueprint, a system-wide ultrasound platform with Compass software that integrates into a healthcare system's clinical and administrative infrastructure. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as clinical support and services. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 65.90M | 73.39M | 62.57M | 46.25M | 27.58M | 1.53M |
| Cost of Revenue | 49.04M | 33.93M | 45.51M | 107.48M | 48.48M | 2.26M |
| Gross Profit | 16.86M | 39.46M | 17.05M | -61.22M | -20.90M | -729.00K |
| Gross Profit Ratio | 25.58% | 53.77% | 27.26% | -132.37% | -75.75% | -47.77% |
| Research & Development | 55.62M | 89.12M | 74.46M | 49.74M | 48.93M | 34.95M |
| General & Administrative | 49.61M | 83.47M | 85.72M | 24.40M | 18.19M | 11.33M |
| Selling & Marketing | 39.07M | 59.89M | 49.60M | 26.26M | 14.28M | 6.08M |
| SG&A | 88.69M | 143.36M | 135.32M | 50.66M | 32.47M | 17.40M |
| Other Expenses | 18.16M | 98.00K | -2.58M | -231.00K | -96.00K | 0.00 |
| Operating Expenses | 162.47M | 232.48M | 209.78M | 100.40M | 81.40M | 52.36M |
| Cost & Expenses | 211.51M | 266.41M | 255.29M | 207.87M | 129.88M | 54.61M |
| Interest Income | 7.45M | 3.38M | 2.57M | 285.00K | 2.70M | 2.32M |
| Interest Expense | 0.00 | 2.00K | 651.00K | 1.14M | 0.00 | 0.00 |
| Depreciation & Amortization | 8.77M | 5.94M | 2.09M | 1.32M | 758.00K | 391.00K |
| EBITDA | -124.84M | -162.74M | -29.55M | -160.25M | -98.94M | -52.70M |
| EBITDA Ratio | -189.44% | -250.17% | -304.71% | -349.31% | -358.70% | -3,453.15% |
| Operating Income | -145.61M | -193.02M | -192.73M | -161.62M | -102.30M | -53.09M |
| Operating Income Ratio | -220.96% | -263.01% | -308.04% | -349.43% | -370.87% | -3,478.77% |
| Total Other Income/Expenses | 11.99M | 24.34M | 160.44M | -1.09M | 2.60M | 2.32M |
| Income Before Tax | -133.62M | -168.68M | -32.29M | -162.71M | -99.70M | -50.77M |
| Income Before Tax Ratio | -202.76% | -229.84% | -51.61% | -351.78% | -361.44% | -3,326.67% |
| Income Tax Expense | 82.00K | 42.00K | 121.00K | 39.00K | -96.00K | 0.00 |
| Net Income | -133.70M | -168.72M | -32.41M | -162.75M | -99.60M | -50.77M |
| Net Income Ratio | -202.88% | -229.90% | -51.80% | -351.87% | -361.10% | -3,326.67% |
| EPS | -0.65 | -0.84 | -0.19 | -26.87 | -17.06 | -9.63 |
| EPS Diluted | -0.65 | -0.84 | -0.19 | -26.87 | -16.45 | -9.63 |
| Weighted Avg Shares Out | 205.39M | 199.85M | 173.81M | 6.06M | 5.84M | 5.27M |
| Weighted Avg Shares Out (Dil) | 205.39M | 199.85M | 173.81M | 6.06M | 6.06M | 5.27M |
Butterfly Network to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference
Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner
Butterfly Network Enters the Bladder Scanning Market With First Specialty Product, iQ+ Bladder, in the United States
5 Medical Info Systems Stocks to Buy for Stable Returns
Butterfly Network, Inc. (BFLY) Q1 2024 Earnings Call Transcript
Butterfly Network Reports First Quarter 2024 Financial Results
Butterfly Network to Report First Quarter 2024 Financial Results on May 1, 2024
Butterfly Network, Clinton Health Access Initiative, and Global Ultrasound Institute Partner to Advance Maternal and Fetal Health in South Africa
Butterfly Network Obtains EU MDR Certification for Butterfly iQ+ Devices in Key European Markets
Butterfly Network Announces Successful Investor Day
Source: https://incomestatements.info
Category: Stock Reports